Articles from The Foundation for the National Institutes of Health

The Foundation for the National Institutes of Health (FNIH) announces that the Food and Drug Administration (FDA) has qualified the treatment-related change in hip bone mineral density (BMD) as a surrogate endpoint for bone fractures in clinical trials of anti-osteoporosis drugs in post-menopausal women at risk for osteoporotic fracture.

The Foundation for the National Institutes of Health (FNIH) has named Howard Y. Chang, M.D., Ph.D., of Stanford University, as the recipient of the 2024 Lurie Prize in Biomedical Sciences. Dr. Chang and his team revealed the vital importance of long noncoding RNA – genetic material that does not code for proteins – in gene regulation and its impact on human diseases, including cancer and autoimmunity.

The Foundation for the National Institutes of Health (FNIH) announces that Love Collins, III, has joined as Vice President of Advancement. In this role, he will serve as the FNIH’s chief development officer and will lead efforts to expand the portfolio of resources and help accelerate the launch of new collaborative biomedical research programs and related scientific efforts in support of the NIH.

The Foundation for the National Institutes of Health (FNIH) today announces the launch of a new public-private partnership to develop tools to identify pregnant women at high risk of early-onset preeclampsia. The project is part of the FNIH Biomarkers Consortium and is a collaboration with the National Institutes of Health (NIH) and eight other partners representing life sciences companies, academia, and nonprofit and patient advocacy organizations.

The Foundation for the National Institutes of Health (FNIH) today announces the online publication of the first “playbook” designed to help accelerate the development of adeno-associated virus (AAV) gene therapies for rare diseases.

The Foundation for the National Institutes of Health (FNIH) has awarded its sixth annual Trailblazer Prize for Clinician-Scientists to Vinod Balachandran, M.D., at Memorial Sloan Kettering Cancer Center (MSK), for his groundbreaking research on immunotherapies for pancreatic cancer. The FNIH’s Trailblazer Prize recognizes the outstanding contributions of early career clinician-scientists whose research translates basic discovery research into novel approaches for diagnosing, preventing, treating, or curing disease and disability.

The Foundation for the National Institutes of Health (FNIH) has named Navdeep S. Chandel, Ph.D., of Northwestern University Feinberg School of Medicine, and Vamsi Mootha, M.D., of Howard Hughes Medical Institute and Harvard Medical School, as recipients of the 2023 Lurie Prize in Biomedical Sciences. Each has made important and distinct discoveries in the field of mitochondrial science by exploring the characteristics and functions of mitochondria in human physiology and disease.